<code id='AF2F0BC205'></code><style id='AF2F0BC205'></style>
    • <acronym id='AF2F0BC205'></acronym>
      <center id='AF2F0BC205'><center id='AF2F0BC205'><tfoot id='AF2F0BC205'></tfoot></center><abbr id='AF2F0BC205'><dir id='AF2F0BC205'><tfoot id='AF2F0BC205'></tfoot><noframes id='AF2F0BC205'>

    • <optgroup id='AF2F0BC205'><strike id='AF2F0BC205'><sup id='AF2F0BC205'></sup></strike><code id='AF2F0BC205'></code></optgroup>
        1. <b id='AF2F0BC205'><label id='AF2F0BC205'><select id='AF2F0BC205'><dt id='AF2F0BC205'><span id='AF2F0BC205'></span></dt></select></label></b><u id='AF2F0BC205'></u>
          <i id='AF2F0BC205'><strike id='AF2F0BC205'><tt id='AF2F0BC205'><pre id='AF2F0BC205'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:365
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          Cytokinetics CEO stresses company can launch heart drug on its own
          Cytokinetics CEO stresses company can launch heart drug on its own

          CytokineticsCEORobertBlumspokeThursdayatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Prior authorization reform is both possible and imperative

          AdobeImaginethisscene:Youareacancerpatientalreadynavigatingfearanduncertaintyaroundyourtreatment,whe